Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Colaboración

Año: 2020

Casabonne, D; Benavente, Y; Seifert, J; Costas, L; Armesto, M; Arestin, M; Besson, C; Hosnijeh, FS; Duell, EJ; Weiderpass, E; Masala, G; Kaaks, R; Canzian, F; Chirlaque, MD; Perduca, V; Mancini, FR; Pala, V; Trichopoulou, A; Karakatsani, A; La Vecchia, C;

Título: INTERNATIONAL JOURNAL OF CANCER

• Q1